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Summary 
An early and essential event in the protective immune response against most viruses and proto- 
zoa is the production of interferon-',/  (IFN-~).  In contrast,  during infection with African try- 
panosomes, protozoan parasites that cause human sleeping sickness, the increased levels of IFN-~ 
do not correlate with a protective response. We showed previously that African trypanosomes 
express a protein called T  lymphocyte triggering factor (TLTF), which triggers CD8 + T  lym- 
phocytes to proliferate and to secrete IFN-~. Here, we isolate the gene for TLTF and demon- 
strate that the recombinant version of TLTF specifically induces CD8 +, but not CD4 +, T  cells 
to secrete IFN-% Studies with TLTF fused to the green fluorescent protein show that TLTF is 
localized to small vesicles that are found primarily at or near the flagellar pocket, the site of se- 
cretion in trypanosomes. TLTF is likely to be only the first example of a class of proteins that 
we designate as trypanokines, i.e., factors secreted by trypanosomes that modulate the cytokine 
network of the host immune system for the benefit of the parasite. 
can trypanosomiasis is a widespread,  fatal disease  in 
ca that is commonly called sleeping sickness in hu- 
mans and ngana in cattle. These diseases are caused by sev- 
eral different species or subspecies of Trypanosoma,  which are 
transmitted by tsetse flies to the bloodstream of their mam- 
malian  hosts  where  they  circulate  extracellularly  and  can 
eventually affect the  central nervous system. Mortality oc- 
curs from either massive parasitosis or secondary infections 
due to immunosuppression, an important trait of the disease. 
Previously,  we  showed  that  trypanosomes  release  a  T 
lymphocyte triggering factor  (TLTF) i  that  induces  CD8 + 
T  cells to secrete IFN-~/(1, 2); subsequent studies indicated 
that  TLTF  binds  to  the  CD8  molecule  on  T  cells  (3). 
When rodents are infected with  Trypanosoma  brucei, IFN-y 
production in the spleen increases markedly. Moreover, in 
rats  depleted  of CD8 +  T  cells  by injection  of anti-CD8 
monoclonal antibody or in knockout mice carrying a dele- 
tion  of the  CD8  gene,  a  trypanosome  infection  does  not 
induce as  much  /FN-~/  production,  the  parasitemia  is  de- 
creased and the infected animals survive longer (3).  In pas- 
1Abbreviations used in this  paper: ADF, adult T cell leukemia-derived factor; 
GFP, green fluorescent protein; GST, glutathione-S-transferase; IGIF, in- 
terferon-~/-inducing factor; THIO, thioredoxin; TLTF, T  lymphocyte 
triggering factor. 
sire immunotherapy experiments,  a mouse monoclonal an- 
tibody directed against TLTF greatly reduces parasite levels 
in, and increases survival of, animals infected with  T.  brucei 
(4, 5). Here, we identify the gene for TLTF and show that 
bacterially  expressed  TLTF has  T  cell stimulatory activity 
that is inhibited by monoclonal antibodies raised against the 
native protein.  We further show that  TLTF has sequence 
similarity with a mammalian protein and that the subcellu- 
lar localization of a green fluorescent protein  (GFP)-TLTF 
fusion  protein  is  consistent  with  that  expected  for  a  se- 
creted protein. 
Materials and Methods 
Molecular Biology Procedures.  The  TLTF  cDNA  was  identi- 
fied by immunoscreening a kZaplI cDNA library of bloodstream 
T.  b.  rhodesiense KNA (6) with rabbit  antiserum against a~nity- 
purified TLTF (4) at a 1:2000 dilution. The antiserum was pread- 
sorbed with Escherichia coli lysate before use. The secondary anti- 
body was a horseradish  peroxidase-linked donkey anti-rabbit IgG 
(Amersham Corp., Arlington Heights, IL) used at a 1:5000 dilu- 
tion. At all stages, a 5% solution of  nonfat powdered milk was used to 
block nonspecific binding. Potentially positive plaques were detected 
using  the  enhanced  chemiluminescent  system  (Amersham  Corp., 
Arlington  Heights,  IL)  and  taken  through two  more  rounds  of 
screening.  The cDNA sequence was determined by standard  se- 
quencing procedures using the Sequenase 2.0 kit (US Biochemicals, 
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using the BLAST algorithm (7). Protein sequence alignments were 
done using the University of Wisconsin GCG software package (8). 
The recombinant thioredoxin (THIO) and glutathione-S-trans- 
ferase  (GST)  fusion proteins were  generated according to  pro- 
tocols  provided  by  the  supplier  of  the  expression  plasmids 
(AMRAD, Australia; Invitrogen, California). The PCR amplified 
fragments of the TLTF cDNA that were cloned into the expres- 
sion plasrnids  contained the  TLTF start  codon  and either  the 
complete TLTF open reading frame or the first 145 codons. Bac- 
terial lysates were fractionated by SDS-PAGE to resolve the fu- 
sion proteins. Rabbits and mice were immunized with crushed 
gel slices containing the fusion protein (THIO-TLTF) or with 
fusion protein that  had been further purified by electroelution 
and dialysis (GST-TLTF) according to standard  procedures (9). 
Plasmid DNA containing the gene for GST-OV7 was the gift of 
Dr. J. Catmull (University of Iowa, Iowa City, IA). 
The  T.  brucei expression  vector pHD-GFPm3 was generated 
by replacing the luciferase gene ofpHD1 (10) with the GFPmut3 
gene  (11). This mutant version of GFP gives  30- to  100-fold 
greater fluorescence  than wild-type GFP from Aquorea victoria. To 
generate the GFP-TLTF fusion construct, EcoRI sites were in- 
troduced in front of the  GFP stop  codon and the  TLTF start 
codon via PCR amplification of the corresponding genes  using 
GFP- or TLTF-specific primers,  which included an EcoRI re- 
striction site. In the case of TLTF, we used the same approach  to 
introduce a BamHI site immediately following the  TLTF stop 
codon. The TLTF open reading frame was then cloned in frame 
behind the GFP gene to generate pHD-GFPm3-TLTF. 
DNA  Transfections.  Procyclic  trypanosomes  (clone  YTATI.1, 
obtained from E. Ullu, Yale University, New Haven, CT) were 
maintained in  Cunningham's SM  medium  (12) supplemented 
with 20% FCS. Cells were harvested from mid-log phase cultures 
(2-4 X 106 cells/ml), washed once with electroporation medium 
(120  mM  KC1, 0.15  mM  CaC12, 10  mM  K2HPO4,  25  mM 
Hepes,  2 mM EDTA, 5 mM MgC12, pH 7.6) and resuspended in 
the same buffer at 1-3 ×  108 cells/ml. DNA (50 Ixg) was intro- 
duced into cells by electroporation  with a BioRad Gene Pulser us- 
ing two pulses of 1,500  V at 25  btF in 0.4 cm cuvettes.  Trans- 
fected cells were transferred to fresh culture medium and examined 
for GFP expression  16-24 h after transfection.  For ethidium bro- 
mide  staining,  cells were  incubated with  2  mg/ml  ethidium 
bromide for 15 rain, then washed twice with PBS. Cells were ex- 
anfined using a  BioRad MRC-1024  Laser  Scanning Confocal 
Microscope. 
IFN-T Assays.  Purification of native TLTF, isolation of mono- 
nuclear  cells and the  spot  assay for  IFN-"/ secretion were  per- 
formed as described  previously (1, 3, 4). The final concentration 
of concanavalin A in the assays was 5 Ixg/ml.  The final concen- 
tration of monoclonal antibody MO1  was  5  ~g/ml. All assays 
were conducted using cells from CD4-CD8  + mice except where 
indicated. The origin of the CD4-CD8 + and CD4+CD8  -  mice 
were described  earlier  (13). Most of the assays for IFN-'y secre- 
tion that  involved the  recombinant fusion proteins were  con- 
ducted blind using protein prepared in the United States and sent 
in coded tubes to Sweden, and were done at least in triplicate. 
Results  and Discussion 
A  monoclonal antibody, called MO1, was used to affin- 
ity purify TLTF from bloodstream trypanosome extracts. 
Monovalent polyspecific antiserum directed against the af- 
finity-purified  protein was generated in rabbits and used to 
immunoscreen a  cDNA  expression library of total  RNA 
isolated from bloodstream forms of T.  b.  rhodesiense,  a sub- 
species that causes the human disease  (6).  A  cDNA clone 
was identified that remained immunopositive through mul- 
tiple rounds of screening. The nucleotide sequence of this 
cDNA revealed that it was a partial length clone lacking the 
39 nucleotide sequence of the 5' spliced leader, a  universal 
feature of trypanosome mRNAs. A  full-length coding se- 
quence was  obtained from the  product of a  reverse tran- 
scriptase-PCR  amplification of total  trypanosome  RNA 
using an internal 3' primer derived from the TLTF partial 
cDNA sequence and a  5'  primer matching the  5'  spliced 
leader sequence. Fig. 1 shows the deduced 453-amino acid 
sequence  of the  encoded  protein,  a  54-kD  hydrophilic 
polypeptide. 
The  amino  acid  sequence  of TLTF  bears  no  obvious 
similarity to  IGIF (IFN-y-inducing factor),  a  protein re- 
cently identified in mouse liver that  induces IFN-y pro- 
duction by CD4 + T  lymphocytes (14). The lack of similar- 
ity between  these  two  proteins  may  be  because  IGIF is 
thought to target CD4 + cells, whereas TLTF interacts spe- 
cifically  with  the  CD8  molecule.  However,  computer 
searches did identify similarities to two other sequences that 
have been deposited in GenBank without further charac- 
terization. One encodes a  mouse protein of 489  residues 
designated as  a  growth  arrest-specific protein.  The  other 
protein is encoded by a randomly sequenced human cDNA 
Figure  1.  Predicted amino 
acid  sequence of  TLTF  and 
comparison to a mouse growth 
arrest~pecific protein. The try- 
panosome cDNA sequence pre- 
dicts  a  hydrophilic, 453-amino 
acid protein  of 54  kD.  In the 
alignment with the mouse pro- 
tein  (GenBank accession No. 
U19589) similar  amino acid resi- 
dues, including  conservative  sub- 
stitutions, are outlined and posi- 
tions of identity are shaded. The 
two proteins exhibit 59% amino 
acid similarity  and 35% identity. The deduced protein encoded by a human expressed sequence tag (dbEST accession No. W21172) is nearly identical 
(87%) to the mouse protein and also displays 34% identity with TLTF (data not shown). The trypanosome TLTF sequence data are available from 
EMBL/GenBank/DDBJ under accession  number AF012853. 
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Figure 2.  Antisera directed against the two different forms of recombi- 
nant TLTF inhibit interfere with the activity of native TLTF. (A) Results 
obtained with antisera raised against THIO-TLTF. P and I denote preim- 
mune and immune serum, respectively. ~t-THIO-TLTF #1 is serum di- 
rected against a fusion protein  containing the  entire  TLTF molecule. 
~t-THIO-TLTF #4 is serum directed against a fusion protein containing 
only the NH2-terminal 145 amino acids of TLTF. ¢t-gp63 is serum di- 
rected against an unrelated Leishmania chagasi protein, gp63 (30); ~t-Tc is 
serum directed against a recombinant version of an unrelated Trypanosoma 
cruzi antigen, gp72 (31) (the gift ofK. Otsu and L.V. Kirchhoff, Univer- 
sity of Iowa, Iowa City, IA). The dilution of serum used in each case was 
1:5,000. (B) Results obtained with 0t-GST-TLTF #1, a rabbit antiserum 
directed against a GST fusion protein containing the entire TLTF protein 
(1:1,000 dilution). 
from a fetal lung cDNA library. Comparison of these pro- 
teins with  TLTF  reveals several regions of high  sequence 
identity (Fig. 1).  Although the properties and functions of 
these  two  mammalian  proteins  are  yet  to  be  described, 
their percent identity to TLTF (35% identity, 58% similar- 
ity) appears too large to be fortuitous. 
The  trypanosome cDNA was  cloned into two  different 
bacterial expression systems in which the NH2-terminal fu- 
sion partner is either GST or THIO.  In each case, a PCR- 
derived fragment of the TLTF cDNA was cloned such that 
435  Vaidya et al. 
the methionine start codon is in frame with the last amino 
acid codon in the GST or THIO  gene. In the THIO  case, 
an  additional clone  was  constructed  in  which  the  TLTF 
segment  terminates  at  codon  145.  The  recombinant pro- 
teins were  used to  generate polyclonal sera in rabbits and 
mice. Each serum was then tested for its inhibition of the 
ability of native TLTF to induce T  cells to secrete IFN-y. 
Fig. 2 A  shows that rabbit antisera directed against either of 
the two versions of THIO-TLTF  (#1 and #4) reduced the 
activity of native TLTF  to  the background levels seen in 
the  absence  of TLTF.  Similarly,  mouse  antiserum  raised 
against a separate aliquot of THIO-TLTF  #1  also reduced 
the  activity  of native  TLTF  to  background  levels.  The 
presence  of the  corresponding preimmune  serum  did not 
significantly  diminish  TLTF  activity.  In  control  experi- 
ments, rabbit antiserum against Leishmania chagasi gp63 and 
mouse  antiserum  against  Trypanosoma  cruzi  gp72  (each  of 
which is a surface protein of its respective parasite) had no 
effect on  the biological activity of native TLTF.  Fig. 2  B 
shows  that similar results were  obtained in parallel experi- 
ments using rabbit antiserum directed against the GST-TLTF 
fusion protein. 
The THIO  and GST fusion proteins were also tested for 
TLTF activity, i.e., the ability to induce T  cells to secrete 
IFN-'y. Fig. 3 A  shows that GST-TLTF induces IFN-',/se- 
cretion from  CD8 +,  but not  CD4 +,  T  cells. The  spleno- 
cytes used in these assays were obtained from gene knock- 
out mice that lacked either the CD4 gene or the CD8 gene 
(13).  Similar to native TLTF, the GST-TLTF  fusion pro- 
tein  induced  IFN-',/  secretion  only  from  the  population 
containing CD8 + cells and not from the cells derived from 
CD8  knockout mice.  Control experiments in which con- 
canavalin A  was used as a mitogen demonstrated that both 
populations  of cells were  intrinsically capable of secreting 
IFN-~ in response t.o an appropriate signal. Fig. 3  B  dem- 
onstrates in a separate series of experiments that the ability 
of GST-TLTF  to  induce  IFN-~/  secretion  is  specifically 
due  to  the  TLTF  portion  of the  molecule.  Neither  GST 
alone  nor  another  unrelated  GST  fusion  protein,  GST- 
OV7,  possessed  an  activity significantly greater  than  the 
background level. In similar experiments not shown, THIO- 
TLTF, also possessed a similar level of TLTF activity. 
Next,  we examined whether antibodies that specifically 
recognize the native TLTF molecule can inhibit the activ- 
ity  of recombinant  TLTF.  We  previously  demonstrated 
that the monoclonal antibody MO1  reduces the ability of 
native TLTF to induce  IFN-y secretion from CD8 +  cells 
(4).  Fig. 4  shows the results obtained when  the activity of 
GST-TLTF was measured in the presence ofMO1.  Under 
the conditions of the assay, the activity of native TLTF was 
reduced by 62% in the presence of MO1.  Consistent with 
the interpretation that GST-TLTF  is the recombinant ver- 
sion of this protein,  a concomitant decrease of 60% in the 
activity of GST-TLTF  occurred in the presence of MO1. 
In  the  case  of the  unrelated  GST-OVT,  the  number  of 
IFN-y--secreting cells detected in the assay was unaffected 
by the presence or absence ofMO1. 
We previously showed that TLTF is released as a soluble A 
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Figure  3.  Recombinant  TLTF  has  biological activity. (A)  Results 
demonstrating the specificity of GST-TLTF #1 activity on mononuclear 
cells from CD4-CD8  + and CD4+CD8  mice. The  concentrations of 
GST-TLTF  #1  used in the reactions are indicated. (B) Comparison of 
the activities of native TLTF, GST-TLTF  #1,  GST-OV7,  and  GST 
alone. GST-OV7  is an unrelated GST fusion,  protein prepared in the 
same way  as  GST-TLTF.  Assays in  B  were  done  using cells from 
CD4-CD8 + mice. The concentration of the recombinant proteins and 
GST in the assays shown in A and B was 10 p~g/ml. Conconavalin A was 
used at a final concentration of 5 I~g/ml. 
factor from T.  brucei into the culture medium (15)  and yet 
the amino acid sequence of TLTF (see Fig. 1) does not con- 
tain  a  classical  NH2-terminal  signal  sequence  similar  to 
those found in most secreted eukaryotic proteins  (16). Be- 
cause secretion of TLTF is likely essential for its  immuno- 
modulatory function, we investigated how it is targeted to 
the exterior of the cell.  This is an especially relevant ques- 
tion in trypanosomatids, because the entire surface of these 
organisms is covered by a very dense protein coat that re- 
stricts  possible  sites  of endocytosis  and  secretion  to  the 
flagellar pocket (17). This organelle derives from a special- 
ized  invagination  of the  cell  membrane  that  forms at  the 
site where the flagellum emerges from the cell and is rela- 
tively protected from the assaults  of the immune system of 
the host. The kinetoplast of T. brucei is also located near the 
base of the flagellum and serves as a marker for the subcel- 
lular location of the flagellar pocket. 
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Figure 4.  Monoclonal antibody MO1 directed against native TLTF in- 
hibits the biological activity of  both native TLTF and recombinant GST- 
TLTF. The IFN-y assays were conducted in the absence (closed bars) or 
presence (cross-hatched bars) of  MO1. 
To  examine  the  cellular  fate  of TLTF,  we  fused  it  to 
GFP  from Aquorea  victoria  (11).  Constructs  encoding either 
this fusion protein,  or GFP alone,  were expressed in tran- 
siently transfected trypanosomes, which were examined by 
laser scanning confocal microscopy (Fig.  5). Because North- 
ern blot analysis indicated  that TLTF is expressed in both 
procyclic  and  bloodstream  form  trypanosomes  (data  not 
shown), we used the more readily cultured procyclic forms 
for these  transfection  experiments.  Western  blots using an 
~x-GFP  polyclonal  antiserum  (Clonetech,  Palo  Alto,  CA) 
confirmed that transfected trypanosomes were producing a 
protein of the expected size (data not shown).  Cells in the 
bottom  panel  of Fig.  5  were  also  stained  with  ethidium 
bromide to visualize the nucleus and kinetoplast  (red stain- 
ing). As can be seen in the top panel of Fig. 5, GFP alone is 
expressed  evenly  throughout  the  entire  cell.  The  GFP- 
TLTF  fusion  protein,  on  the  other  hand,  is  restricted  to 
vesicles that  are usually,  but  not exclusively,  located at or 
near  the  trypanosome  flagellar  pocket  (Fig.  5,  bottom). 
These  results  are  consistent  with  TLTF  being  a  secreted 
protein,  as  shown  previously  (15),  and  demonstrate  that 
signals for TLTF targeting are located within the protein it- 
self,  even though it does not contain a hydrophobic NH2- 
terminal  signal  sequence.  Thus,  TLTF  is  added  to  the 
growing list of secreted  eukaryotic proteins  for which the 
amino acid sequence gives no indication of a readily identi- 
fiable  targeting  signal  (18).  Interestingly,  many such  pro- 
teins  play a  role  in  immune  system function  (e.g.,  IL-113 
and adult T  cell leukemia-derived factor [ADF]. IL-113 is a 
monocyte-derived,  proinflammatory  cytokine  that  stimu- 
lates  a broad range  of cell types.  ADF mediates  upregula- 
tion  of IL-2 receptor  expression  and  may be  involved in 
the  abnormal  proliferation  of T  cells  observed  in  some 
types  of leukemogenesis  (19).  Although  some  features  of 
export may be shared between leaderless secreted proteins, 
the mechanisms responsible are unknown. Recent data in- 
dicate that multiple mechanisms exist (20)  and that two dif- 
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nals direct  a  heterologous  re- 
porter protein  (GFP) to vesicles 
that are localized to the trypano- 
some flageUar pocket.  Procyclic 
T.  brucei cells were  transiently 
transfected with  a  T.  brucei ex- 
pression plasmid containing  the 
GFP gene alone (top) or a plas- 
mid encoding a GFP-TLTF fu- 
sion protein  (bottom). The trans- 
fected  cells were  examined  by 
laser scanning confocal micros- 
copy and the transmitted and flu- 
orescent  images were  superim- 
posed  on  one  another.  GFP 
fluorescence  is  green.  Cells  in 
the bottom panel were addition- 
ally stained with  ethidium  bro- 
mide to visualize  the nucleus and 
kinetoplast  (red staining).  The 
white bar corresponds to 10 Jxm. 
ferent  proteins  may  utilize  partially, but  not  completely, 
overlapping pathways (21). 
TLTF is likely to be the first confirmed member of a ca- 
bal of trypanosome-derived, immunomodulatory factors for 
which  we  suggest  the  name  trypanokines.  Trypanosomal 
cysteine protease, which is found in the serum of infected 
animals  (22-24),  is another potential trypanokine, because 
cysteine proteases of other microorganisms have been shown 
to  modulate  cytokine  activity either  directly or indirectly 
(25, 26). Still other unknown mitogenic trypanosome mol- 
ecules have been proposed previously to be the cause of the 
massive nonspecific polyclonal activation of B  cells during 
acute  trypanosomiasis  (27).  Parallels  have  already  been 
drawn between gene rearrangements that generate the anti- 
body repertoires in vertebrates and those responsible for the 
perpetual  antigenic  variation  in  trypanosomes  (28).  Try- 
panokines  represent another  example of the  ability of the 
trypanosome to mimic a normal host function; in this case, 
the  synthesis  of cytokines that  modulate  the  immune  re- 
sponse.  Recent  experiments  with  viruses  and  infectious 
bacteria indicate that this  strategy may also be  commonly 
used by other microbial pathogens (25, 29).  In this regard, 
the availability of the TLTF gene should facilitate novel ap- 
proaches  towards  achieving  protection  against  trypanoso- 
miasis. In addition, recombinant TLTF could find applica- 
tions  in  the  treatment  of other  infectious  agents,  such  as 
Leishmania and viruses, for which IFN-~/production is among 
the first events of a protective response. 
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